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| INTRODUC TI ON
As the sixth leading cause of cancer-associated death, esophageal cancer results in approximately 400 000 mortalities globally every year. 1, 2 In Asian countries, ESCC remains the predominant histologic type of esophageal cancer. 3, 4 Despite incremental advancement in diagnostics and therapeutics, its prognosis remains poor with a 5-year survival rate of 15%-25%. 2 As a result, there remains an urgent need to elucidate the molecular mechanisms underlying ESCC progression. Recent studies focused on the dynamic changes of the immune system in cancer progression. 5 Actually, growing evidence has raised a bidirectional regulatory role of the immune system in facilitating tumor growth, with several studies reporting that the immune system can recognize tumor cells and restrain cancer progression. 6, 7 In oncoimmunology, the balance between immune-effective and immunosuppressive cells has aroused great attention. Moreover, a growing number of studies have begun to focus on how these cells regulate the tumor microenvironment. Among immune regulatory cells, robust predictive value has been endowed to the regulatory T cells that participate in tumor progression with immunosuppressive functions. 8 Although current immunotherapeutic strategies focus on T cell-mediated immunity, in recent years, growing research has assigned a critical role to B cells, which could act as immunoregulatory factors in modulating carcinogenesis and cancer progression. hi CD27 + phenotypes in human. 11 Great attention has been paid on the relationships between various types of cancers and B10, including gastric cancer and breast cancer. 12 Recently, a novel PD-1 hi regulatory B-cell subset has been identified that is associated with tumor stage and early recurrence in human hepatocellular carcinoma. 13 However, the association between ESCC and B10 cells and PD-1 hi Bregs remains unclear.
In the tumor microenvironment, the proliferation and differentiation of B cells can be regulated by cancer cells through exosomes in glioma and Burkitt's lymphoma. [14] [15] [16] Moreover, studies showed that proteins and RNAs that are packaged into the exosomes are highly stable. 17, 18 Exosomes are small membrane vesicles of endocytic origin and act as cargos to deliver specific genetic messages to the target cells and further modulate their phenotype and biological processes. 19 Hence, we mainly observed the functions of exosomes from ESCC in B cell modulation.
Here, we assessed the ratio of B10 cells in the peripheral blood from ESCC patients. Moreover, we explored the modulatory effects of exosomes in the differentiation of B cells into B10 and PD-1 hi B cells. Tables 1 and S1 .
| MATERIAL S AND ME THODS

| Patients and serum samples
| Cell culture
As we previously reported, ESCC cell line (ECA109) was cultured in DMEM with 10% FBS (Gibco) in a humid environment at 37°C containing 5% CO 2. 
| Isolation and identification of exosomes
The exosomes in peripheral blood samples from patients and normal volunteers were purified using ExoQuick exosome precipitation solution (System Biosciences). 
| Transmission electron microscopy
After fixed by glutaraldehyde and paraformaldehyde, exosomes were loaded on carbon-coated electron microscopy grids and then negatively labeled with methylamine tungstate. A transmission electron microscope was used to capture the microscopy images (Zeiss).
| Nanoparticle tracking analysis
The size distribution of isolated extracellular vesicles was measured using Nanosight (Malvern) and NTA analytical software (version 2.3; Nanosight).
| Western blot analysis
Exosomes were lysed by RIPA buffer (Roche 
| Isolation and culture of B cells from PBMCs
Human PBMCs were isolated using density gradient centrifugation with Ficoll-Paque Plus (Sigma-Aldrich). Then CD19 + B cells were magnetically purified from the PBMCs using magnetic microbeads (Miltenyi Biotec). Isolated CD19 + B cells were cultured in RPMI-1640 medium supplemented with 1 μg/mL CD40L plus 5 μg/mL antihuman IgM (R&D Systems).
| Interactions between B cells and exosomes
Exosomes were labeled with a PKH26 red fluorescent marker according to the manufacturer's instructions (PKH26GL; Sigma-Aldrich).
The labeled exosomes were diluted in exosome-free medium and incubated with isolated CD19 + B cells labeled with DAPI. The images were obtained with a Zeiss Laser Scanning Confocal Microscope (Zeiss). 
| Cell proliferation assay
| Flow cytometry
| Statistical analysis
Statistical analysis was carried out using GraphPad Prism 6 software.
All data are presented as mean ± SD. The B10 ratio in PBMCs and IL-10 expression level in CD19 + B cells from ESCC patients or healthy controls were compared using the Mann-Whitney U test. The differences between 2 groups were assessed using Student's t test. P value < .05 was considered as statistically significant.
| RE SULTS
| Expansion of B10 cells in PBMCs of ESCC patients
We first measured the percentage of B10 cells (CD19
in PBMCs from ESCC patients (n = 30) and healthy donors (n = 30).
Clinical data of the 30 ESCC patients are listed in Table 1 These results suggested the potential modulatory role of B10 cells in ESCC progression.
| Exosome characterization
Peripheral blood-derived exosomes were visualized by electron microscopy imaging (Figure 2A-C) . NTA showed that the particle size distribution of purified exosomes from the peripheral blood and ECA109 cell line, ESCC patients, and healthy controls were between 30 and 120 nm ( Figure 2D-F) . The expression of specific exosome markers (CD9 and CD81) on exosomes from the peripheral blood and ECA109 cell line, ESCC patients and healthy controls was validated by western blot analysis ( Figure 2G ). These data confirmed that exosomes were purified from the peripheral blood of ECA109 cell line, ESCC patients and healthy controls.
| Internalization of circulating exosomes by B cells
The CD19 + B cells were purified from the peripheral blood of healthy 
| Circulating exosomes from ESCC mediated differentiation of B cells
We next assessed the modulatory ability of circulating exosomes from ESCC patients (ESCC-Exo), healthy donors (norm-Exo), and 
| Comparison of RNA expression profiles between ESCC-Exo and norm-Exo and function annotation
The mRNAs and lncRNAs delivered by exosomes were shown to be functional, which could be translated into protein or act as competing endogenous RNAs in the recipient cells. 19 To understand the biological mechanism underlying the modulatory effects of exosomes, we downloaded the high throughput sequencing data (GSE104926), including lncRNA and mRNA expression profiles, from Gene Expression Omnibus.
The mRNA and lncRNA profiling was undertaken using the Subsequently, we applied GO biological process enrichment and KEGG signaling pathways analysis to explore the regulatory mechanism underlying the ESCC exosomes. As shown in Figure 6A , differentially expressed mRNAs were enriched in GO terms such as the TLR4 signaling pathway (GO: 0034145) and MAPK cascade (GO: 0000165), which induced the conversion of PD-1 hi Bregs. 13 In order to explore the protein interactions and determine the hub genes, we plotted the protein-protein interaction network of differentially expressed genes enriched in the TLR4 signaling pathway and MAPK. NRAS and MAPK12 were identified as hub genes, which were considered highly correlated with other genes in the network and played critical roles in modulating conversion of PD-1 hi Breg cells ( Figure 6B ). 13 Similarly, in the KEGG signaling pathway analysis, differentially expressed mRNAs were enriched in KEGG terms including the B-cell receptor signaling pathway (has 04662) and MAPK signaling pathway ( Figure 6C ). The protein-protein interaction network showed that MAP3K2 and RAP1B were hub genes in the MAPK signaling pathway and might participate in the differentiation of PD-1 hi Breg cells ( Figure 6D ). It has been reported that activation of the TLR4-BCL6 axis contributes to PD-1 hi Bregs. 13 In addition, mRNAs in the exosomes have been reported to be functional, which could be translated into protein and exert biological effects in the recipient cells. 19 Hence, we compared the mRNAs in exosomes from ESCC and healthy donors.
| D ISCUSS I ON
By applying gene annotation and enrichment analyses, we found a series of differentially expressed mRNAs that play a role in the TLR4
and MAPK signaling pathways. A previous report showed that the activation of MAPKs in B cells exposed to multifarious stimuli coincided with the ability of the cells to express BCL6, which is activated by TLR4. 13 Furthermore, activation of the MAPK and TLR4 pathways also enhanced the IL-10 production of B cells and mediated the conversion of B10 cells. 41 Hence, ESCC-derived exosomes could lead to the activation of TLR4 and MAPK signaling pathways and lead to PD-1 expression and IL-10 secretion in recipient B cells. 
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